Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

TMR with PLC Systems' Heart Laser continues to display efficacy

July 5, 1996

First launch for Ciba-Geigy angiotensin II antagonist

July 5, 1996

Warner-Lambert reports nonpeptide ET antagonists

July 5, 1996

Norvasc labeling revised by FDA

June 28, 1996

SmithKline Beecham antiarrhythmic research revealed

June 28, 1996

PLC Systems' CO2 Heart Laser deemed effective in angina patients

June 28, 1996

Phospholipase A2 inhibitors for atherosclerosis treatment

June 28, 1996

Sankyo will seek FDA approval for temocapril HCl in 1997

June 28, 1996

Neurex seeks FDA approval for Corlopam

June 28, 1996

Endothelin antagonists in Kyowa Hakko's pipeline

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...